ConductScience.org, home

Paper3191663

Difference between beta-1-selective and non-selective beta-blockade during continuous and intermittent exercise.

Gullestad L and 3 others. Clin Physiol, 1988. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Difference between beta-1-selective and non-selective beta-blockade during continuous and intermittent exercise. Papers, record 3191663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3191663

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Difference between beta-1-selective and non-selective beta-blockade during continuous and intermittent exercise.
PubMed
Journal
Clin Physiol
PubMed
Year
1988
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2019-09-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gullestad LL
2Dolva LOL O
3Søyland EE
4Kjekshus JJ

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ExerciseMajor topic
MetoprololMajor topic
Physical EnduranceMajor topic
TimololMajor topic
Administration, Oral
Adult
Blood Pressure
Double-Blind Method
Humans
Male
Middle Aged
Oxygen Consumption
Potassium
Random Allocation

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
29793358The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht Study.J Cardiovasc Pharmacol Ther2019https://conductscience.org/library/papers/29793358PubMed
20595693Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.Clin J Am Soc Nephrol2010https://conductscience.org/library/papers/20595693PubMed
16200423The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise.Eur J Appl Physiol2005https://conductscience.org/library/papers/16200423PubMed
7589026Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/7589026PubMed
1681847Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1681847PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KCNMB13779PubTator's text mininghttps://conductscience.org/library/genes/3779NCBI Gene
MS4A1931PubTator's text mininghttps://conductscience.org/library/genes/931NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3191663

GET https://conductscience.org/api/papers/v1/3191663/authors